Dr. Taddese Teferi Desta, MD

Dr. Desta practices at Digestive Disease Associates in San Diego, California.

Dr. Desta's NPI, 1346326246, was assigned on October 31, 2006. Dr. Desta graduated from OHSU School of Medicine in 1989. Dr. Desta holds California license A49164.

Dr. Desta's primary practice is Digestive Disease Associates, at 292 Euclid Ave, Ste 115, San Diego, CA 92114. The practice phone is (619) 266-3332.

Dr. Desta's primary practice is Digestive Disease Associates in San Diego, California. The medical group on file is Digestive Disease Associates, Inc. Dmand AI also links Dr. Desta to 2 more group practices and clinics and 2 medical groups, each named with a free account. Dr. Desta's employer is on file too: a clinical lab.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Desta practices, 3 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Desta's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Desta is board certified in gastroenterology by the American Board of Internal Medicine. Dr. Desta is licensed in California.

Dmand AI lists acid reflux, arthritis, chronic diabetes, chronic hypertension, cirrhosis of the liver, essential tremor, fatty liver and gastrointestinal bleeding among the conditions Dr. Desta treats.

CMS data shows 472 Medicare services from Dr. Desta across 9 procedure codes in 2024, for 302 Medicare patients. Medicare paid $48,516 for them.

CMS counts 302 Medicare patients who saw Dr. Desta in 2024. The largest group is 65 to 74, with 185 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 76% are also on Medicaid. Their average risk score is 1.30, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Desta's median patient age at 56, with 61% women.

In 2024, Dr. Desta wrote 784 Medicare Part D claims for 379 patients. 67% of them were for generic drugs. CMS names the drug for 663 of them, across 13 drugs with 11 or more claims each, at $151,450 in total drug cost. In 2023, CMS named 619 claims across 13 drugs.

Dr. Desta accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 100 procedures of colonoscopy by Dr. Desta, more than 80% of the clinicians it reports for that procedure.

Dmand AI links 2 papers to Dr. Desta, published from 2018 to 2021. The most frequent topics are Double-Blind Method. Dr. Desta's most frequent co-authors are Charles F. Barish, MD, Brooks Dickson Cash, MD and Douglas S. Denham, DO.

Dmand AI links Dr. Desta to 9 clinical trials, 5 of them phase 3 studies. Conditions studied include Gastroparesis, Abdominal Pain and Constipation. Bausch Health Americas, Inc. sponsors the most, 2.

CMS Open Payments shows 468 general payments to Dr. Desta from 34 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 97% of the total. Abbvie Inc. paid the most, $3,180. It also lists 2 research payments totaling $13,600 from 2021 to 2022.

Dr. Desta graduated from OHSU School of Medicine in 1989.

Dr. Desta is in network with 16 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.